Supreme Court Must Protect Medtech Firms By Upholding Objectively Reasonable Standard, AdvaMed Says
Executive Summary
Changing the scienter standard basis by rejecting objective reasonability in FCA claims will hurt medtech innovation, according to AdvaMed.